Stock BTMD BIOTE CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus biote Corp.

Equities

BTMD

US0906831039

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
5.75 USD -1.54% Intraday chart for biote Corp. -6.05% +16.40%
May. 10 Biote Corp. acquired Certain assets of BioSana ID LLC for $0.8 million. CI
May. 07 Earnings Flash (BTMD) BIOTE Reports Q1 Revenue $46.8M, vs. Street Est of $45.7M MT

Evolution of the average Target Price on biote Corp.

Price target over the last 5 years

History of analyst recommendation changes

5d1d.g5b3bm-7WIfoRYtjTHOMT0U1gzZCGY9QpOoYSKExki8.29ygFgvQacOuGuwMLyDWLjR9wnIhdsdn3ohRB-dE-nfI1cM6I8k2_7kj5A~fada02238e6b6864d06ef7d925c5c9b0

Analyst Recommendations on biote Corp.

B. Riley Ups Price Target on Biote to $10 From $9, Maintains Buy Rating MT
CORRECTION : --B. Riley Lowers Bitcoin Depot's Price Target to $4 From $6, Maintains Buy Rating MT
B. Riley Lowers biote's PT to $4 From $6 After Lower-Than-Expected Q4 2023 Results, Says California Regulations Hit Sales Outlook; Maintains Buy Rating MT
Roth MKM Adjusts Price Target on Biote to $9 From $8, Maintains Buy Rating MT
B. Riley Securities Starts biote With Buy Rating, $9 Price Target MT
Jefferies Starts Biote With Buy Rating, $6.55 Price Target MT
Roth MKM Trims Price Target on Biote to $7 From $8, Maintains Buy Rating MT
TD Cowen Adjusts Price Target on biote to $7 From $12, Maintains Outperform Rating MT
Roth MKM Adjusts Price Target on biote to $11 From $10, Maintains Buy Rating MT
Truist Securities Starts biote at Buy With $10 Price Target MT
Cowen Starts biote at Outperform With $11 Price Target MT
Roth Capital Partners Initiates biote Corp. at Buy, Sets Price Target to $9 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
5.75 USD
Average target price
8.866 USD
Spread / Average Target
+54.19%
High Price Target
10 USD
Spread / Highest target
+73.91%
Low Price Target
7 USD
Spread / Lowest Target
+21.74%

Consensus detail

Consensus revision (last 18 months)

Analysts covering biote Corp.

B. Riley
Roth MKM
Jefferies & Co.
TD Cowen
Truist Securities
Cowen
Roth Capital Partners

Ratings for biote Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BTMD Stock
  4. Consensus biote Corp.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW